FDA approves cancer drug Epkinly from Genmab and Abbvie
Abbvie and Genmab will jointly market the product in the US.
The American drug authority, the Food & Drug Administration (FDA), has approved the cancer drug Epcoritamab, developed by Genmab and AbbVie.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
